The questions buyers ask.

Green Pharma welcomes discussions with licensed cannabis producers and prospective supply partners.

Potential suppliers are assessed based on their licensing and compliance status, product quality, specifications, testing, traceability, available volumes and intended market requirements.

Yes. This is one of the primary reasons Green Pharma was established.

GACP provides the foundation for compliant cultivation and handling of medicinal cannabis, but regulated pharmaceutical markets can require additional GMP manufacturing, quality, testing, packaging and documentation controls before a product can progress through the pharmaceutical supply chain.

Green Pharma was specifically established to provide this critical GMP step, helping bridge the gap between licensed GACP production and the requirements of regulated pharmaceutical markets.

Yes. Green Pharma operates as a SAHPRA-licensed cGMP medicinal cannabis manufacturing facility in South Africa.

Our facility was purpose-built around pharmaceutical quality systems and GMP principles, with a particular focus on providing third-party contract manufacturing and packaging services to the medicinal cannabis industry.

All activities are conducted within Green Pharma’s approved licence scope and applicable regulatory requirements.

Green Pharma currently provides specialised cGMP manufacturing and packaging services within our approved regulatory scope, including primary and secondary packaging, weighing, labelling, controlled product handling, quality management and associated batch documentation.

Green Pharma is also entering its next phase of development. We are progressing plans to significantly expand our facility and broaden our future manufacturing capabilities to include additional processing activities such as extraction, formulation and other value-added pharmaceutical manufacturing services.

These additional capabilities will be introduced subject to the necessary facility development, validation and regulatory approvals.

Green Pharma is currently progressing its EU GMP certification pathway.

Following the successful completion of our South African licensing process, EU GMP represents an important next stage in the development of our facility and international manufacturing capabilities.

Until this certification process has been successfully completed, Green Pharma does not represent itself as EU GMP certified.

Green Pharma was specifically developed with international pharmaceutical standards and regulated markets in mind.

We work with producers, clients and industry partners to understand the manufacturing, quality, packaging, testing and documentation requirements associated with their intended market.

Requirements differ between jurisdictions, and international market access remains subject to the applicable product, regulatory, import, export and destination-country requirements.

Our objective is to provide clients with a strong GMP manufacturing platform capable of supporting increasingly broader regulated market opportunities as Green Pharma continues to expand its capabilities and international certifications.

Not necessarily to start a conversation with us.

Green Pharma welcomes enquiries from licensed producers at different stages of their development. However, products entering a regulated pharmaceutical supply chain must meet the applicable licensing, quality, traceability and regulatory requirements for their intended use and destination.

Our team can assess your current position, product and intended requirements to determine whether Green Pharma can provide an appropriate manufacturing solution.

Green Pharma provides third-party contract packaging services within our approved cGMP manufacturing scope.

Depending on the product and applicable regulatory requirements, this can include primary and secondary packaging and labelling according to agreed client and market specifications.

Packaging configuration, specifications, artwork, regulatory information and quality requirements are reviewed as part of the client onboarding and manufacturing process.

This enables producers, brands and pharmaceutical partners to access established GMP manufacturing infrastructure without having to develop their own dedicated facility.

Requirements vary according to the product, its origin, intended manufacturing activities and destination market.

Green Pharma’s quality assessment may include applicable licensing information, product specifications, batch documentation, traceability records, Certificates of Analysis and other relevant quality and testing documentation.

Where additional requirements apply, these are identified during the assessment and onboarding process.

Our objective is to establish the applicable quality and regulatory requirements before manufacturing activities commence, providing both Green Pharma and our clients with a clear and compliant pathway forward.

The best place to start is a conversation with our team.

Whether you are a licensed producer, pharmaceutical company, brand, international partner or developing a new project, Green Pharma will first seek to understand your current position, product, intended market and manufacturing requirements.

From there, we can assess the project against our current capabilities and regulatory scope, identify any additional requirements and determine an appropriate way forward.

Green Pharma was established to provide more than manufacturing capacity. Our goal is to build long-term partnerships that connect compliant production, pharmaceutical quality and GMP manufacturing with the evolving requirements of regulated markets.